These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25914189)
1. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer. Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189 [TBL] [Abstract][Full Text] [Related]
2. TPX2 siRNA regulates growth and invasion of esophageal cancer cells. Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289 [TBL] [Abstract][Full Text] [Related]
3. TPX2 regulates tumor growth in human cervical carcinoma cells. Jiang P; Shen K; Wang X; Song H; Yue Y; Liu T Mol Med Rep; 2014 Jun; 9(6):2347-51. PubMed ID: 24718984 [TBL] [Abstract][Full Text] [Related]
4. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer. Chang H; Wang J; Tian Y; Xu J; Gou X; Cheng J Oncol Rep; 2012 May; 27(5):1353-9. PubMed ID: 22307108 [TBL] [Abstract][Full Text] [Related]
5. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Warner SL; Stephens BJ; Nwokenkwo S; Hostetter G; Sugeng A; Hidalgo M; Trent JM; Han H; Von Hoff DD Clin Cancer Res; 2009 Nov; 15(21):6519-28. PubMed ID: 19861455 [TBL] [Abstract][Full Text] [Related]
6. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
7. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Zhang L; Huang H; Deng L; Chu M; Xu L; Fu J; Zhu Y; Zhang X; Liu S; Zhou Z; Wang Y Toxicology; 2008 Oct; 252(1-3):49-55. PubMed ID: 18723071 [TBL] [Abstract][Full Text] [Related]
8. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808 [TBL] [Abstract][Full Text] [Related]
9. Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma. Li B; Qi XQ; Chen X; Huang X; Liu GY; Chen HR; Huang CG; Luo C; Lu YC Brain Res; 2010 Sep; 1352():200-7. PubMed ID: 20599806 [TBL] [Abstract][Full Text] [Related]
10. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594 [TBL] [Abstract][Full Text] [Related]
11. TPX2 promotes cell proliferation and migration via PLK1 in OC. Ma S; Rong X; Gao F; Yang Y; Wei L Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033 [TBL] [Abstract][Full Text] [Related]
12. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Morgan-Lappe SE; Tucker LA; Huang X; Zhang Q; Sarthy AV; Zakula D; Vernetti L; Schurdak M; Wang J; Fesik SW Cancer Res; 2007 May; 67(9):4390-8. PubMed ID: 17483353 [TBL] [Abstract][Full Text] [Related]
13. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064 [TBL] [Abstract][Full Text] [Related]
14. TPX2 silencing mediated by joint action of microvesicles and ultrasonic radiation inhibits the migration and invasion of SKOV3 cells. Huang D; Chen J; Yang C; Wang M Mol Med Rep; 2018 Jun; 17(6):7627-7635. PubMed ID: 29620263 [TBL] [Abstract][Full Text] [Related]
15. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer. Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936 [TBL] [Abstract][Full Text] [Related]
16. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794 [TBL] [Abstract][Full Text] [Related]
17. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo. Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297 [TBL] [Abstract][Full Text] [Related]
18. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533 [TBL] [Abstract][Full Text] [Related]
19. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation. Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334 [TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]